Dr. Benson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
460 W 10th Ave
5th Floor
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812- Is this information wrong?
Summary
- Care of people with myeloma | Laboratory, translational, and clinical immunotherapy research for myeloma | Medical education, teaching, and mentorship | Executive Leadership & Professional Development Coaching in medicine and health care
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2003 - 2006
- University of Virginia Medical CenterResidency, Internal Medicine, 1999 - 2003
- Northeast Ohio Medical UniversityClass of 1999
Certifications & Licensure
- OH State Medical License 2003 - 2025
- VA State Medical License 1999 - 2004
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2010 Aug 01
- Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse Start of enrollment: 2010 Sep 01
- A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2011 Oct 13
- Join now to see all
Publications & Presentations
PubMed
- Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma.Michael Ozga, Qiuhong Zhao, Laila Huric, Cecelia Miller, Ashley Rosko, Abdullah Khan, Elvira Umyarova, Don Benson, Francesca Cottini> ;Blood Cancer Journal. 2023 Nov 10
- 1 citationsTTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma.Larissa Valle Guilhen Longo, Tiffany Hughes, Betina McNeil-Laidley, Francesca Cottini, Gerard Hilinski, Elizabeth Merritt, Don M Benson> ;Haematologica. 2024 Feb 1
- Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma.Abdullah M Khan, Kiatlyn Dvorak, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Srinivas Devarakonda, Elvira Umyarova, Nidhi Sharma, Don Benson, Ashley Rosko> ;Haematologica. 2023 Dec 1
- Join now to see all
Journal Articles
- Human AML Activates the AHR Pathway to Impair NK Cell Development and FunctionLuxi Chen, Michael Zhang, Monica Williams, Jennifer N Saultz, Steven D Scoville, Aharon G Freud, Don M Benson, Michael A Caligiuri, Blood
Press Mentions
- Colin Powell Was Fully Vaccinated, but He Still Died from COVID Complications. How Rare Is That?October 18th, 2021
Hospital Affiliations
- Ohio State University Wexner Medical CenterColumbus, Ohio
- The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: